Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
G GENITO URINARY SYSTEM AND SEX HORMONES
G04 UROLOGICALS
G04B UROLOGICALS
G04BE Drugs used in erectile dysfunction
G04BE10 Avanafil
D03217 Avanafil (USAN/INN) <US>
USP drug classification [BR:br08302]
Sexual Disorder Agents
Sexual Disorder Agents (Male)
Avanafil
D03217 Avanafil (USAN/INN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01509 Phosphodiesterase V inhibitor
D03217 Avanafil
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D03217 Avanafil
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Phosphodiesterases
PDE5
D03217 Avanafil (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D03217
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D03217
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D03217
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D03217